Skip to main content
. 2014 Jul 20;2014:949845. doi: 10.1155/2014/949845

Figure 2.

Figure 2

SMCs fail to induce OT-II CD4+ T cell proliferation. Representative plots and relative statistical analysis showing the effect of SMCs on OT-II CD4+ T cell proliferation. IFN-γ-stimulated SMCs were treated with OVA (1 mg/mL) or OVA323–339 peptide (0.5 µg/mL) overnight and then cocultured with CFSE-labeled OT-II CD4+ T cells for 72 h. OVA-treated DCs were used as a positive control. Results are expressed as mean ± SEM from three separate experiments run in triplicate. **P < 0.01 versus OT-II CD4+ T cells alone.